F. Malnique, “USE OF DAPAGLIFLOZIN (FORXIGA) IN THE MANAGEMENT OF OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES”, Editora, pp. 368–379, Nov. 2025, Accessed: Jan. 10, 2026. [Online]. Available: https://sevenpubl.com.br/editora/article/view/8517